272 related articles for article (PubMed ID: 31404528)
41. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera.
Sivasankarapillai VS; Madhu Kumar Nair R; Rahdar A; Bungau S; Zaha DC; Aleya L; Tit DM
Environ Sci Pollut Res Int; 2020 Jul; 27(21):26025-26035. PubMed ID: 32405942
[TBL] [Abstract][Full Text] [Related]
42. Keeping abreast about ashwagandha in breast cancer.
Vashi R; Patel BM; Goyal RK
J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916
[TBL] [Abstract][Full Text] [Related]
43. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
44. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain.
Schliebs R; Liebmann A; Bhattacharya SK; Kumar A; Ghosal S; Bigl V
Neurochem Int; 1997 Feb; 30(2):181-90. PubMed ID: 9017665
[TBL] [Abstract][Full Text] [Related]
45. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine.
Mirjalili MH; Moyano E; Bonfill M; Cusido RM; Palazón J
Molecules; 2009 Jul; 14(7):2373-93. PubMed ID: 19633611
[TBL] [Abstract][Full Text] [Related]
46. The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates.
Abeesh P; Guruvayoorappan C
Curr Mol Med; 2024; 24(4):404-418. PubMed ID: 37076466
[TBL] [Abstract][Full Text] [Related]
47. Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies.
Dom M; Offner F; Vanden Berghe W; Van Ostade X
J Proteomics; 2018 May; 179():17-29. PubMed ID: 29448055
[TBL] [Abstract][Full Text] [Related]
48. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
Lee J; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
[TBL] [Abstract][Full Text] [Related]
49. Withanone-rich combination of Ashwagandha withanolides restricts metastasis and angiogenesis through hnRNP-K.
Gao R; Shah N; Lee JS; Katiyar SP; Li L; Oh E; Sundar D; Yun CO; Wadhwa R; Kaul SC
Mol Cancer Ther; 2014 Dec; 13(12):2930-40. PubMed ID: 25236891
[TBL] [Abstract][Full Text] [Related]
50. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
51. Phytochemistry, Food Application, and Therapeutic Potential of the Medicinal Plant (
Khan MI; Maqsood M; Saeed RA; Alam A; Sahar A; Kieliszek M; Miecznikowski A; Muzammil HS; Aadil RM
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833974
[TBL] [Abstract][Full Text] [Related]
52. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases.
Kuboyama T; Tohda C; Komatsu K
Biol Pharm Bull; 2014; 37(6):892-7. PubMed ID: 24882401
[TBL] [Abstract][Full Text] [Related]
53. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives.
Rai M; Jogee PS; Agarkar G; dos Santos CA
Pharm Biol; 2016; 54(2):189-97. PubMed ID: 25845640
[TBL] [Abstract][Full Text] [Related]
54. Molecular insights into cancer therapeutic effects of the dietary medicinal phytochemical withaferin A.
Chirumamilla CS; Pérez-Novo C; Van Ostade X; Vanden Berghe W
Proc Nutr Soc; 2017 May; 76(2):96-105. PubMed ID: 28162105
[TBL] [Abstract][Full Text] [Related]
55. Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopy.
Namdeo AG; Sharma A; Yadav KN; Gawande R; Mahadik KR; Lopez-Gresa MP; Kim HK; Choi YH; Verpoorte R
Planta Med; 2011 Nov; 77(17):1958-64. PubMed ID: 21728148
[TBL] [Abstract][Full Text] [Related]
56. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression.
Hahm ER; Singh SV
Cancer Lett; 2013 Jun; 334(1):101-8. PubMed ID: 22935676
[TBL] [Abstract][Full Text] [Related]
57. Potential Anticancer Properties and Mechanisms of Action of Withanolides.
Samadi AK
Enzymes; 2015; 37():73-94. PubMed ID: 26298456
[TBL] [Abstract][Full Text] [Related]
58. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study.
Cai Z; Zhang G; Tang B; Liu Y; Fu X; Zhang X
Cell Biochem Biophys; 2015 Jul; 72(3):727-39. PubMed ID: 25627548
[TBL] [Abstract][Full Text] [Related]
59. Quantitative HPLC analysis of withanolides in Withania somnifera.
Ganzera M; Choudhary MI; Khan IA
Fitoterapia; 2003 Feb; 74(1-2):68-76. PubMed ID: 12628397
[TBL] [Abstract][Full Text] [Related]
60. Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.
Lee IC; Choi BY
Int J Mol Sci; 2016 Mar; 17(3):290. PubMed ID: 26959007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
